Post-earnings recap
Reported
Mon, Feb 9, 2009
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported an EPS of $0.59, exceeding expectations by 6.88%. However, the stock fell by 1.86% following the earnings release. The lack of revenue figures and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.59 | N/A | +6.88% |
No transcript is on record, and the analysis is based on numerical results only.